InvestorsHub Logo
Followers 51
Posts 8843
Boards Moderated 2
Alias Born 05/29/2007

Re: None

Wednesday, 01/04/2017 11:11:26 AM

Wednesday, January 04, 2017 11:11:26 AM

Post# of 3159
Some more basic info I found. If anyone can dig up anything else on this Low Floating Monster it would be great.

About Q BioMed

Q BioMed logoQ BioMed, Inc., formerly ISMO Tech Solutions, Inc., is a biomedical acceleration and development company. The Company is focused on licensing, acquiring and providing strategic resources to life sciences and healthcare companies. The Company intends to acquire multiple assets over time and across a spectrum of healthcare related products, companies and sectors. The Company intends to develop these assets to provide returns through organic growth, out-licensing, sale or spin-off into new public companies. The Company holds license for a generic drug, Strontium Chloride (SR89). SR89 is a radiopharmaceutical agent and indicated for the treatment of pain associated with metastatic bone cancer. Its asset, MAN-01, is indicated for the treatment of glaucoma. MAN-01 is in pre-clinical stage. The Company is assessing multiple biomedical assets in various areas of healthcare and drug development. It is pursuing a pipeline of therapeutics, diagnostics and orphan drug candidates.

Industry, Sector and Symbol: •Sector: N/A
•Industry: N/A
•Sub-Industry: N/A
•Exchange: NASDAQ
•Symbol: QBIO
•CUSIP:
Key Metrics:
•Previous Close: $5.94
•50 Day Moving Average: $4.07
•200 Day Moving Average: $3.27
•52-Week Range: $1.26 - $8.00
•Trailing P/E Ratio: N/A
•P/E Growth: 0.00
•Market Cap: $70.86M
Additional Links:
•View QBIO on Google Finance
•View QBIO on Yahoo Finance
•View QBIO's Company Profile on Reuters
•Search for Q BioMed Inc on Google

•Much success can be attributed to inactivity. Most investors cannot resist the temptation to constantly buy and sell.
•Only buy something that you’d be perfectly happy to hold if the market shut down for 10 years.
Warren Buffett